- Symptoms and diagnosis
- Usage examples
- Medicinal plants
- Frequent searches
- Medical search
- Health topics
- Healthy weight
- Medical dictionary
- Health sites
- Questions and answers
|Boston Strategics Corporation Initiates a Phase 1 Clinical Trial of the Anti ...|
MDS is a type of hematologic malignancy, in which the disorder of blood-forming "hematopoietic stem cells" causes inefficient production of blood cells triggering cytopenia. It is also a refractory disease for some patients with poor prognosis ...
PipelineReview.com (press release) - Fri, 29 Aug 2014 12:07
|Find Order In Chaos With This Kinetic Sculpture That Captures The Essence Of ...|
The work of a biotechnology company like Biogen Idec--a Cambridge, Massachusetts-based company that specializes in medicines for people with neurodegenerative diseases, hematologic conditions and autoimmune disorders--is hard to explain.
Co.Create - Tue, 26 Aug 2014 05:56
|Should Ovaries Be Removed at the Time of Hysterectomy?|
Fibroids, bleeding abnormalities, endometrial pathology, adenomyosis, endometriosis, and various cancers or precancerous diseases may require the removal of the uterus as part of treatment. The ovaries serve an important endocrine function, and their ...
Medscape - Thu, 28 Aug 2014 09:07
|Leukemia Admissions on Weekends Result in Longer Hospital Stays|
... our pediatric oncology units," said senior researcher Richard Aplenc, MD, PhD, associate professor of pediatrics at the Perelman School of Medicine at the University of Pennsylvania and section chief for hematologic malignancies in the division of ...
Medscape - Wed, 27 Aug 2014 08:32
|Intercept Pharmaceuticals Inc. (ICPT), Bristol-Myers Squibb Co (BMY), Biogen ...|
Biogen Idec Inc (NASDAQ:BIIB) is an independent biotechnology company engaged in development of innovative therapies for the treatment of neurodegenerative diseases, hematologic conditions and autoimmune disorders. Its market cap is $81.2 billion.
Insider Monkey (blog) - Thu, 28 Aug 2014 13:37
|New Tool Clarifies Drug Reimbursement for Cancer Patients|
A new tool that evaluates insurance coverage for specific cancer therapies might be useful for oncologists and their patients weighing different treatment options. RxAssistance, from MolecularHealth, offers "value-added benefit" for patients and ...
Medscape - Wed, 27 Aug 2014 12:52
|Identification of 102 genes may help classify, treat patients with ...|
These genes also may provide novel targets for therapy, researchers wrote. Jerry L. Spivak, MD, director of the Center for Chronic Myeloproliferative Disorders at Johns Hopkins Medicine, and colleagues used oligonucleotide microarray technology to ...
Healio - Wed, 27 Aug 2014 14:10
|Dell CIO Karaboutis Bolts For Biogen|
Biogen develops therapies for neurodegenerative diseases, hematologic conditions and autoimmune disorders. "As the pace of digital innovation accelerates, Andi will play a critical role in our mission to improve human health and support those who serve ...
CruxialCIO - Mon, 25 Aug 2014 06:18